Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide, Toripalimab, and Paclitaxel in Early Breast Cancer
NCT05749575Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in breast cancer, sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
tucidinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05749575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05749575.